- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Cabot Stock Crosses Above 200-Day Average - Should You Sell?
Shares of the specialty chemicals company have risen above a key technical indicator, prompting analyst reviews.
Apr. 19, 2026 at 3:08pm
Got story updates? Submit your updates here. ›
The heavy, industrial machinery and mechanics of the banking system provide a visual metaphor for the stability and security that investors seek, even as Cabot's stock crosses a key technical threshold.Boston TodayShares of Cabot Corporation (NYSE:CBT), a global specialty chemicals and performance materials company headquartered in Boston, crossed above their 200-day moving average during trading on Friday. The stock price reached as high as $75.40 before closing at $74.46 with over 350,000 shares traded. Analysts have issued a mix of ratings on the stock, with some recommending a hold while others see potential for further gains.
Why it matters
Cabot's stock crossing above the 200-day moving average is a technical indicator that can signal a potential shift in the stock's momentum and future performance. This development will likely prompt closer scrutiny from investors and analysts as they assess whether the company's fundamentals support further upside or if the current valuation presents an opportunity to sell.
The details
Several equity research analysts have recently weighed in on Cabot's stock. UBS Group raised their price target from $74 to $81 and maintained a 'neutral' rating, while Zacks Research upgraded the stock from 'strong sell' to 'hold'. Jefferies Financial Group reaffirmed a 'buy' rating with an $85 price target. Overall, the analyst consensus is 'hold' with a $73.75 average price target.
- Cabot's stock crossed above its 200-day moving average of $70.01 during trading on Friday, April 19, 2026.
- In its most recent quarterly earnings report on February 3, 2026, Cabot posted EPS of $1.53, exceeding analyst estimates of $1.40.
The players
Cabot Corporation
A global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882, Cabot serves a wide range of end markets including automotive, industrial, energy, and consumer products.
UBS Group
A global investment bank and financial services firm that has issued a 'neutral' rating and raised its price target on Cabot's stock.
Zacks Research
An investment research firm that has upgraded Cabot's stock from 'strong sell' to 'hold'.
Jefferies Financial Group
A global investment banking firm that has reaffirmed a 'buy' rating and $85 price target on Cabot's stock.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident
The takeaway
Cabot's stock crossing above its 200-day moving average is a technical milestone that will likely prompt closer analysis from investors and analysts. While the analyst consensus is 'hold', the mixed ratings and price targets suggest there is uncertainty around whether the current valuation presents an opportunity for further gains or if it's time for shareholders to consider selling.
Boston top stories
Boston events
Apr. 19, 2026
Wild Kratts Live 2.0 - Activate Creature Power!Apr. 19, 2026
Disney's Beauty and the Beast (Touring)Apr. 19, 2026
Wild Kratts Live 2.0 - Activate Creature Power!




